![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Direxion Daily Financial Bull 3X Shares ETF
FAS
Spdr S&P Bank Etf
KBE
Ultra Financials Proshares
UYG
4
SPDR S&P Metals & Mining ETF
XME
5
SPDR S&P Retail ETF
XRT
US Stock MarketDetailed Quotes
Moleculin Biotech (MBRX)
- 4.690
- +0.190+4.22%
Close Dec 16 16:00 ET
- 4.400
- -0.290-6.18%
Post 19:06 ET
9.68MMarket Cap-0.09P/E (TTM)
4.780High4.360Low103.21KVolume4.470Open4.500Prev Close472.25KTurnover5.12%Turnover RatioLossP/E (Static)2.06MShares91.24852wk High-0.35P/B9.46MFloat Cap4.36052wk Low--Dividend TTM2.02MShs Float18292.500Historical High--Div Yield TTM9.33%Range %4.360Historical Low4.575Avg Price1Lot Size
MBRX Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
MBRX Orderflow
Unit: --
MBRX Orderflow Trend
IntradayDayWeekMonth
No Data
Moleculin Biotech (MBRX) News
Moleculin Biotech Regains Nasdaq Compliance
Roth MKM Maintains Moleculin Biotech(MBRX.US) With Buy Rating, Maintains Target Price $31
Roth MKM Maintains Moleculin Biotech(MBRX.US) With Buy Rating, Cuts Target Price to $31
Moleculin Biotech Target Adjusted to $31 From $300 at Roth Capital
Moleculin Biotech Price Target Raised to $22.00/Share From $4.00 by HC Wainwright & Co.
Moleculin Biotech Is Maintained at Buy by HC Wainwright & Co.
Moleculin Biotech (MBRX) Stock Forum
$Moleculin Biotech (MBRX.US)$ On December 15, 2025, the Company received a letter from the Staff notifying the Company that it had regained compliance with the Bid Price Rule as a result of the closing bid price of the Company’s common stock being at $1.00 per share or greater for the 10 consecutive business days from December 1, 2025 through December 12, 2025. Accordingly, the letter indicated the Company is in compliance with the Bid Price Rule and the matter is closed.
⭐️⭐️Calling all of my 20K followers and my brother Trytosaveabit's ~10K followers to consider showing appreciation or support by VOTING so we get to help more people ![]()
⬇️⬇️⬇️
2025 Mooers of the Year: Voting Is Open! Pick Your Top 10!
⚠️ READ THIS BEFORE YOU TRADE ⚠️
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, ...
⬇️⬇️⬇️
2025 Mooers of the Year: Voting Is Open! Pick Your Top 10!
⚠️ READ THIS BEFORE YOU TRADE ⚠️
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, ...
+8
17
2
$Moleculin Biotech (MBRX.US)$ Moleculin Biotech Price Target Raised to $22.00/Share From $4.00 by HC Wainwright & Co.
1
1
$Moleculin Biotech (MBRX.US)$ This company is going bust soon?
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)